Mancini M. P023 | SETD2 loss in chronic myeloid leukemia promotes metabolic reprogramming and genomic instability leading to therapeutic resistance and disease progression: <a href="https://haematologica.org/search/search?query=M.+Mancini">M. Mancini</a>1|2, <a href="https://haematologica.org/search/search?query=L.+Romagnoli">L. Romagnoli</a>2, <a href="https://haematologica.org/search/search?query=S.+De+Santis">S. De Santis</a>2, <a href="https://haematologica.org/search/search?query=S.+Bruno">S. Bruno</a>2, <a href="https://haematologica.org/search/search?query=A.+Tagliavia">A. Tagliavia</a>2, <a href="https://haematologica.org/search/search?query=C.+Mosca">C. Mosca</a>2, <a href="https://haematologica.org/search/search?query=A.+Oldani">A. Oldani</a>1, <a href="https://haematologica.org/search/search?query=A.+Merlotti">A. Merlotti</a>3, <a href="https://haematologica.org/search/search?query=D.+Remondini">D. Remondini</a>3, <a href="https://haematologica.org/search/search?query=E.+Esposito">E. Esposito</a>4, <a href="https://haematologica.org/search/search?query=J.+Fiori">J. Fiori</a>4, <a href="https://haematologica.org/search/search?query=F.+Castagnetti">F. Castagnetti</a>1|2, <a href="https://haematologica.org/search/search?query=M.+Iezza">M. Iezza</a>2, <a href="https://haematologica.org/search/search?query=R.+Restuccia">R. Restuccia</a>2, <a href="https://haematologica.org/search/search?query=M.+Lasala">M. Lasala</a>2, <a href="https://haematologica.org/search/search?query=A.+Iurlo">A. Iurlo</a>5, <a href="https://haematologica.org/search/search?query=M+Cerrano">M Cerrano</a>6, <a href="https://haematologica.org/search/search?query=S.+Galimberti">S. Galimberti</a>7, <a href="https://haematologica.org/search/search?query=P.+L.+Zinzani">P. L. Zinzani</a>1|2, <a href="https://haematologica.org/search/search?query=S.+Soverini">S. Soverini</a>1 | 1IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”; 2Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna; 3Department of Physics and Astronomy "DIFA", Università di Bologna; 4Dipartimento di Chimica "Giacomo Ciamician", Università di Bologna; 5UO Onco-ematologia, Fondazione IRCCS Ca’ Granda - Ospedale Policlinico; 6A. O. U. Citta della Salute e della Scienza di Torino; 7Clinical and Experimental Medicine, Hematology, University of Pisa. .. Haematologica;111(s1):; https://doi.org/10.3324/haematol.2026.s1.94.